The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.
Open accessAbstract
We investigated the antigen specificity and presentation requirements for inactivation of T lymphocytes in vitro and in vivo. In vitro studies revealed that splenocytes treated with the crosslinker 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (ECDI) and soluble antigen fragments failed to stimulate significant proliferation by normal pigeon cytochrome c-specific T cell clones, suggesting that the chemical treatment inactivated full antigen presentation function. However, T cell clones exposed to ECDI-treated splenocytes and antigen in vitro were rendered unresponsive for at least 8 d to subsequent antigen stimulation with normal presenting cells. As predicted by the in vitro results, specific T cell unresponsiveness was also induced in vivo in B10.A mice injected intravenously with B10.A, but not B10.A(4R), splenocytes coupled with pigeon cytochrome c via ECDI. The antigen and MHC specificity of the induction of this T cell unresponsiveness in vitro and in vivo was identical to that required for T cell activation. These results suggest that nonmitogenic T cell recognition of antigen/MHC on ECDI-modified APCs results in the functional inactivation of T cell clones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A rapid method for the isolation of functional thymus‐derived murine lymphocytes
Julius, M. H., Simpson, E., & Herzenberg, L. A. (1973) · European Journal of Immunology · doi:10.1002/eji.1830031011 · Cited by 4,147
Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*
Ledbetter, J. A., & HERZENBERG, L. A. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00289.x · Cited by 1,914
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
Properties of Monoclonal Antibodies to Mouse Ig Allotypes, H-2, and Ia Antigens
Oi, V. T., Jones, P. P., Goding, J. W., Herzenberg, L. A., & Herzenberg, L. A. (1979) · Lymphocyte Hybridomas · doi:10.1007/978-3-642-67448-8_18 · Cited by 973
Schwartz, R. (1985) · Annual Review of Immunology · doi:10.1146/annurev.immunol.3.1.237 · Cited by 932
Self-citationHybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.
Ozato, K., Mayer, N., & Sachs, D. H. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.2.533 · Cited by 837
Weiss, A., & Stobo, J. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00163 · Cited by 565
Bhattacharya, A., Dorf, M. E., & Springer, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2488 · Cited by 525
Cellular Mechanisms of Immunologic Tolerance
Nossal, G. J. V. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.000341 · Cited by 516
Weiss, A., Wiskocil, R. L., & Stobo, J. D. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.1.123 · Cited by 471
Cited by
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
Self-citationSharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., & Dazzi, F. (2003) · Blood · doi:10.1182/blood-2002-07-2104 · Cited by 1,598
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
Self-citationCombination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
Apoptosis And Programmed Cell Death In Immunity
Cohen, J. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.267 · Cited by 1,111
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
Fife, B. T., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00662.x · Cited by 1,054
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
Kearney, E. R., Pape, K. A., Loh, D. Y., & Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 946
Self-citationTolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., et al. (2002) · Nature Immunology · doi:10.1038/ni760 · Cited by 800
Negative selection of lymphocytes
Nossal, G. J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90331-x · Cited by 785
Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells
Ridge, J. P., Fuchs, E. J., & Matzinger, P. (1996) · Science · doi:10.1126/science.271.5256.1723 · Cited by 760
Sloan-Lancaster, J., & Allen, P. M. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.1 · Cited by 676
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Schietinger, A., & Greenberg, P. D. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.001 · Cited by 673
Signals required for programming effector and memory development by CD8+ T cells
Mescher, M. F., Curtsinger, J. M., Agarwal, P., Casey, K. A., Gerner, M., Hammerbeck, C. D., Popescu, F., & Xiao, Z. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00382.x · Cited by 601
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
Joffre, O., Nolte, M. A., Spörri, R., & Sousa, C. R. E. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00718.x · Cited by 598
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
Wells, A. D., Li, X. C., Li, Y., Walsh, M. C., Zheng, X. X., Wu, Z., Nuñez, G., Tang, A., Sayegh, M., Hancock, W. W., et al. (1999) · Nature Medicine · doi:10.1038/15260 · Cited by 596
The enemy within: keeping self-reactive T cells at bay in the periphery
Walker, L. S. K., & Abbas, A. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri701 · Cited by 596
SLOANLANCASTER, J. (1994) · Cell · doi:10.1016/0092-8674(94)90080-9 · Cited by 594
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
Sloan-Lancaster, J., Evavold, B. D., & Allen, P. M. (1993) · Nature · doi:10.1038/363156a0 · Cited by 587
Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C., & Bluestone, J. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1145 · Cited by 583
B Cells Turn Off Virgin But Not Memory T Cells
Fuchs, E. J., & Matzinger, P. (1992) · Science · doi:10.1126/science.1439825 · Cited by 562
Models of T cell anergy: is there a common molecular mechanism?
Schwartz, R. H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.1 · Cited by 559
Self-citationSeparation of IL-4 Production from Th Cell Proliferation by an Altered T Cell Receptor Ligand
Evavold, B. D., & Allen, P. M. (1991) · Science · doi:10.1126/science.1833816 · Cited by 549
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Targeting tumours with genetically enhanced T lymphocytes
Sadelain, M., Rivière, I., & Brentjens, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc971 · Cited by 535
Dustin, M. L. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0161 · Cited by 502
“Jenkins and Schwartz (67) discovered that antigen recognition with suboptimal costimulation could induce a state of nonresponsiveness that they named anergy.”
BackgroundCurrent Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
Prabhakar, B. S., Bahn, R. S., & Smith, T. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0020 · Cited by 489
Differentiation of T Regulatory Cells by Immature Dendritic Cells
Roncarolo, M.-G., Levings, M. K., & Traversari, C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.f5 · Cited by 483
Gene vaccination with naked plasmid DNA: mechanism of CTL priming.
Corr, M., Lee, D. J., Carson, D. A., & Tighe, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1555 · Cited by 475
Wells, A. D., Gudmundsdottir, H., & Turka, L. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119873 · Cited by 471
Belz, G. T., Behrens, G. M. N., Smith, C. M., Miller, J. F. A. P., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020861 · Cited by 467
Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A., & Linsley, P. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.165 · Cited by 461
Kamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 457
Rammensee, H.-G., Kroschewski, R., & Frangoulis, B. (1989) · Nature · doi:10.1038/339541a0 · Cited by 449
Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. H. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.
Goodnow, C. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2264 · Cited by 446
Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus
Sarzotti, M., Robbins, D. S., & Hoffman, P. M. (1996) · Science · doi:10.1126/science.271.5256.1726 · Cited by 446
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells
Spada, F. M., Koezuka, Y., & Porcelli, S. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1529 · Cited by 438
Recent advances in the discovery and delivery of vaccine adjuvants
O'Hagan, D. T., & Valiante, N. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1176 · Cited by 434
Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T Cells
Li, W., Whaley, C. D., Mondino, A., & Mueller, D. L. (1996) · Science · doi:10.1126/science.271.5253.1272 · Cited by 427
Bacchetta, R., Bigler, M., Touraine, J. L., Parkman, R., Tovo, P. A., Abrams, J., de Waal Malefyt, R., de Vries, J. E., & Roncarolo, M. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.493 · Cited by 416
Maintenance of Human T Cell Anergy: Blocking of IL-2 Gene Transcription by Activated Rap1
Boussiotis, V. A., Freeman, G. J., Berezovskaya, A., Barber, D. L., & Nadler, L. M. (1997) · Science · doi:10.1126/science.278.5335.124 · Cited by 409
IL-10–producing T cells suppress immune responses in anergic tuberculosis patients
Boussiotis, V. A., Tsai, E. Y., Yunis, E. J., Thim, S., Delgado, J. C., Dascher, C. C., Berezovskaya, A., Rousset, D., Reynes, J.-M., & Goldfeld, A. E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9918 · Cited by 398
Transcriptional regulation in the immune system: all roads lead to AP-1
Foletta, V. C., Segal, D. H., & Cohen, D. R. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.2.139 · Cited by 390
Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal
Takahashi, C., Mittler, R. S., & Vella, A. T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5037 · Cited by 379
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
Pollizzi, K. N., & Powell, J. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3701 · Cited by 379
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M.-G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 376
Approaching the Asymptote: 20 Years Later
Medzhitov, R. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.004 · Cited by 373
Blocked Ras Activation in Anergic CD4 + T Cells
Fields, P. E., Gajewski, T. F., & Fitch, F. W. (1996) · Science · doi:10.1126/science.271.5253.1276 · Cited by 370
Anergic T Cells as Suppressor Cells in Vitro
Lombardi, G., Sidhu, S., Batchelor, R., & Lechler, R. (1994) · Science · doi:10.1126/science.8202711 · Cited by 366
CD28, CTLA‐4 and their ligands: who does what and to whom?
Sansom, D. M. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00121.x · Cited by 362
Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments
Di Marco Barros, R., Roberts, N. A., Dart, R. J., Vantourout, P., Jandke, A., Nussbaumer, O., Deban, L., Cipolat, S., Hart, R., Iannitto, M. L., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.030 · Cited by 362
Uncovering of Functional Alternative CTLA-4 Counter-Receptor in B7-Deficient Mice
Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., et al. (1993) · Science · doi:10.1126/science.7694362 · Cited by 359
Transgenic Mice and Analysis of B-Cell Tolerance
Goodnow, C. C. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.002421 · Cited by 359
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
Guinan, E., Gribben, J., Boussiotis, V., Freeman, G., & Nadler, L. (1994) · Blood · doi:10.1182/blood.v84.10.3261.3261 · Cited by 358
In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.
Rellahan, B. L., Jones, L. A., Kruisbeek, A. M., Fry, A. M., & Matis, L. A. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1091 · Cited by 357
Gene vaccination: plasmid DNA is more than just a blueprint
Tighe, H., Corr, M., Roman, M., & Raz, E. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01201-2 · Cited by 352
At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
Callahan, M. K., & Wolchok, J. D. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212631 · Cited by 348
Udono, H., Levey, D. L., & Srivastava, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3077 · Cited by 347
Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells
Lo, D., Burkly, L. C., Widera, G., Cowing, C., Flavell, R. A., Palmiter, R. D., & Brinster, R. L. (1988) · Cell · doi:10.1016/0092-8674(88)90497-7 · Cited by 340
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
Zang, X., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1030 · Cited by 336
Self-Tolerance Checkpoints in B Lymphocyte Development
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60633-1 · Cited by 328
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
Granier, C., De Guillebon, E., Blanc, C., Roussel, H., Badoual, C., Colin, E., Saldmann, A., Gey, A., Oudard, S., & Tartour, E. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000213 · Cited by 324
Transactivation by AP-1 Is a Molecular Target of T Cell Clonal Anergy
Kang, S.-M., Beverly, B., Tran, A.-C., Brorson, K., Schwartz, R. H., & Lenardot, M. J. (1992) · Science · doi:10.1126/science.257.5073.1134 · Cited by 318
Self-citationInduction of classical transplantation tolerance in the adult.
Qin, S. X., Cobbold, S., Benjamin, R., & Waldmann, H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.779 · Cited by 317
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
Miller, S. D., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., Dal Canto, M. C., & Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90063-2 · Cited by 315
NF-κB Subunit Regulation in Nontransformed CD4 + T Lymphocytes
Kang, S.-M., Tran, A.-C., Grilli, M., & Lenardo, M. J. (1992) · Science · doi:10.1126/science.1604322 · Cited by 314
Mechanism of cellular rejection in transplantation
Ingulli, E. (2010) · Pediatric Nephrology · doi:10.1007/s00467-008-1020-x · Cited by 313
The immunological synapse and CD28-CD80 interactions
Bromley, S. K., Iaboni, A., Davis, S. J., Whitty, A., Green, J. M., Shaw, A. S., Weiss, A., & Dustin, M. L. (2001) · Nature Immunology · doi:10.1038/ni737 · Cited by 311
T cell anergy and costimulation
Appleman, L. J., & Boussiotis, V. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00009.x · Cited by 305
The costimulatory function of antigen-presenting cells
Weaver, C. T., & Unanue, E. R. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90018-5 · Cited by 303
Hunter, Z., McCarthy, D. P., Yap, W. T., Harp, C. T., Getts, D. R., Shea, L. D., & Miller, S. D. (2014) · ACS Nano · doi:10.1021/nn405033r · Cited by 301
Pattern recognition receptors: function, regulation and therapeutic potential
Chen, R., Zou, J., Chen, J., Zhong, X., Kang, R., & Tang, D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02264-1 · Cited by 301
Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Chused, T. M., & Schwartz, R. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5409 · Cited by 298
Self-citationDeSilva, D. R., Jones, E. A., Favata, M. F., Jaffee, B. D., Magolda, R. L., Trzaskos, J. M., & Scherle, P. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4175 · Cited by 295
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.
Ho, W. Y., Cooke, M. P., Goodnow, C. C., & Davis, M. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1539 · Cited by 292
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease
Miller, S. D., Turley, D. M., & Podojil, J. R. (2007) · Nature Reviews Immunology · doi:10.1038/nri2153 · Cited by 290
Kuniyasu, Y., Takahashi, T., Itoh, M., Shimizu, J., Toda, G., & Sakaguchi, S. (2000) · International Immunology · doi:10.1093/intimm/12.8.1145 · Cited by 290
Rincón, M., & Flavell, R. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06757.x · Cited by 289
Powell, J. D., Lerner, C. G., & Schwartz, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2775 · Cited by 289
Self-citationThe type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice
Zhang, J., Lee, S.-M., Shannon, S., Gao, B., Chen, W., Chen, A., Divekar, R., McBurney, M. W., Braley-Mullen, H., Zaghouani, H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38902 · Cited by 287
Costimulatory and coinhibitory receptors in anti‐tumor immunity
Driessens, G., Kline, J., & Gajewski, T. F. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00771.x · Cited by 286
Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J.-P., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006168 · Cited by 281
Corneal response to Pseudomonas aeruginosa infection
Hazlett, L. D. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.002 · Cited by 278
CTLA4Ig: Bridging the Basic Immunology with Clinical Application
Bluestone, J. A., St. Clair, E. W., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.001 · Cited by 276
Harding, F. A., & Allison, J. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1791 · Cited by 265
Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases
Morante-Palacios, O., Fondelli, F., Ballestar, E., & Martínez-Cáceres, E. M. (2021) · Trends in Immunology · doi:10.1016/j.it.2020.11.001 · Cited by 263
Microglia induce CD4 T lymphocyte final effector function and death.
Ford, A. L., Foulcher, E., Lemckert, F. A., & Sedgwick, J. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1737 · Cited by 262
Yip, H. C., Karulin, A. Y., Tary-Lehmann, M., Hesse, M. D., Radeke, H., Heeger, P. S., Trezza, R. P., Heinzel, F. P., Forsthuber, T., & Lehmann, P. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3942 · Cited by 258
Schwartz, R. H. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80081-7 · Cited by 255
Self-citationE3 ubiquitin ligases as T cell anergy factors
Mueller, D. L. (2004) · Nature Immunology · doi:10.1038/ni1106 · Cited by 224
Role of the Guanosine Triphosphatase Rac2 in T Helper 1 Cell Differentiation
Li, B., Yu, H., Zheng, W.-P., Voll, R., Na, S., Roberts, A. W., Williams, D. A., Davis, R. J., Ghosh, S., & Flavell, R. A. (2000) · Science · doi:10.1126/science.288.5474.2219 · Cited by 141
Metadata
- Authors
- Jenkins, M. K., & Schwartz, R. H.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1987-02-01
- Volume
- 165
- Issue
- 2
- Pages
- 302-319
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2125504851
- Cited by
- 1,170
- References
- 28
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.